Showing results (21-30 of 404) with videos related to
Sort By:
Pageof 41
Cancer Management and Research|August 15, 2022
Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician's PerspectiveTakashi Matsumoto, Masaki Shiota, Leandro Blas, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|July 17, 2026
Post-Marketing Surveillance of the Safety and Effectiveness of Cabozantinib in Japanese Patients With Advanced Renal Cell CarcinomaHiro-Omi Kanayama, Shingo Kuroda, Tsuyoshi Osaka, et al.Neurourology and Urodynamics|October 29, 2020
Symptoms and noninvasive test parameters that clinically differentiate detrusor underactivity from bladder outlet obstruction without a pressure-flow-based diagnosis in men with lower urinary tract symptomsRyosuke Takahashi, Mineo Takei, Ryo Namitome, et al.Cancer Science|June 9, 2017
Potential overtreatment among men aged 80 years and older with localized prostate cancer in JapanHiroyuki Masaoka, Hidemi Ito, Akira Yokomizo, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|July 13, 2006
Clinical outcomes and learning curve of a laparoscopic adrenalectomy in 103 consecutive cases at a single instituteMasatoshi Eto, Masahiko Harano, Hirofumi Koga, et al.Urologic Oncology|November 14, 2022
Steroidogenesis in castration-resistant prostate cancerMasaki Shiota, Satoshi Endo, Leandro Blas, et al.Cancer Immunology, Immunotherapy : CII|November 6, 2025
Biology and evolving management of resectable dMMR/MSI-H cancers: current status and future perspectivesTokiyoshi Tanegashima, Masaki Shiota, Kayo Toyosaki, et al.Cancers|November 11, 2022
Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for CancerTakahito Kawano, Junichi Inokuchi, Masatoshi Eto, et al.Pharmaceutics|November 27, 2021
Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical TrialsTakahito Kawano, Junichi Inokuchi, Masatoshi Eto, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Promotion of skin graft tolerance across MHC barriers by mobilization of dendritic cells in donor hemopoietic cell infusionsMasatoshi Eto, Holger Hackstein, Katsuhiko Kaneko, et al.Pageof 41